Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single‑center cohort study
Article in Oncology Letters (August 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Oncology Letters (August 2024)
Article in Chinese Journal of Experimental Surgery (June 2024)
Article in Journal of Allergy and Clinical Immunology Global (May 2024)